To corroborate NBN's CNAmp and overexpression in ovarian cancer, we further experimentally quantified NBN gene copy number and protein expression in an independent cohort of 31 serous ovarian cancer samples using droplet digital PCR and immunohistochemistry respectively. The gene discussed is NBN; the disease is ovarian serous adenocarcinoma.